Why Does Aromatase Vary by Genetics? The CYP19A1 Explanation
Aromatase activity varies between men because CYP19A1 — the gene encoding aromatase — is polymorphic. Different CYP19A1 variants alter how the enzyme is expressed and how efficiently it converts testosterone to estradiol. The Precision Peptide Genetic Test analyzes CYP19A1 as part of 14 pathways and 150+ genetic insights across 49 peptides.
Can Genetic Testing Predict TRT Response? What It Actually Tells You
Not exactly — but the answer matters. The Precision Peptide Genetic Test doesn't predict whether a specific androgen protocol will work. It maps six biological variables that determine how testosterone behaves in your body: SHBG, CYP19A1, AR, SRD5A2, LHCGR, and CYP17A1. Part of 14 pathways and 150+ genetic insights, that map is the most actionable starting point available.
What Is the Reproductive Health Pathway in Genetic Testing?
In the Precision Peptide Genetic Test, the Reproductive Health pathway delivers 6 insights across genes governing testosterone bioavailability, estrogen conversion, androgen receptor sensitivity, DHT production, and HPTA axis function. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 insights map male hormone balance as a connected genetic system.
How Does Genetics Affect Estrogen in Men? A Gene-by-Gene Guide
Genetics shapes estrogen in men through four pathways: how much testosterone converts to estradiol (CYP19A1), how efficiently it clears (COMT, MTHFR), how sensitively tissues respond (ESR1), and how much substrate is available (SHBG, SRD5A2). The Precision Peptide Genetic Test maps all these variables across 14 pathways and 150+ genetic insights.
Does SHBG Genetics Affect TRT? What Providers Should Know
Yes — SHBG genetics directly affect how free testosterone responds to androgen-pathway protocols. The Precision Peptide Genetic Test analyzes SHBG variants as part of 14 pathways and 150+ genetic insights across 49 peptides, giving providers the genetic context to understand why the same protocol produces different free testosterone outcomes in different men.
What Genes Affect Testosterone Levels? The Complete Genetic Guide
The Precision Peptide Genetic Test analyzes six Reproductive Health genes that directly influence testosterone levels, conversion, and signaling — including SHBG, CYP19A1, AR, SRD5A2, LHCGR, and CYP17A1. Part of 14 pathways and 150+ genetic insights across 49 peptides, these variants explain why testosterone behaves differently in different men.
Why TRT Works for Some Men and Not Others: The Genetic Answer
The Precision Peptide Genetic Test analyzes 6 Reproductive Health insights that explain why androgen-pathway protocols produce different outcomes for different men. SHBG, CYP19A1, AR, SRD5A2, LHCGR, and CYP17A1 each shape how testosterone is bound, converted, sensed, and signaled — as part of 14 pathways and 150+ genetic insights across 49 peptides.
SRD5A2 and 5-Alpha Reductase Genetics: DHT Conversion in Men
The Precision Peptide Genetic Test analyzes SRD5A2 — the gene controlling 5-alpha reductase, the enzyme that converts testosterone into DHT. Part of 14 pathways and 150+ genetic insights across 49 peptides, your SRD5A2 variants determine how much testosterone is routed toward the androgen pathway's most potent signaling molecule.
Androgen Receptor CAG Repeats: Sensitivity Explained
The Precision Peptide Genetic Test analyzes AR CAG repeats — the genetic variable that determines how sensitively your androgen receptor responds to testosterone. Part of 14 pathways and 150+ genetic insights across 49 peptides, CAG repeat length helps explain why two men with identical testosterone levels can have completely different androgen responses.
CYP19A1 (Aromatase) and Estrogen Conversion in Men
The Precision Peptide Genetic Test analyzes CYP19A1 — the aromatase gene that controls how much testosterone your body converts to estrogen. Part of 14 pathways and 150+ genetic insights across 49 peptides, your CYP19A1 variants help explain why estrogen levels vary between men on the same androgen-pathway protocol.
Complete Guide to Genetic Men's Hormone Testing: 6 Pathway Insights
The Precision Peptide Genetic Test analyzes 6 Reproductive Health insights covering men's hormone pathways — SHBG, CYP19A1, AR, SRD5A2, and LH/FSH receptor variants — within a panel of 14 pathways, 49 peptides, and 150+ genetic insights. This pillar guide breaks down each gene, what it reveals about testosterone response, and why DNA is the most underused variable in hormone protocols.
SHBG Genetics: Why Your Free Testosterone Varies
SHBG — sex hormone-binding globulin — determines how much of your testosterone is biologically available to cells. High SHBG binds more testosterone, reducing free levels; low SHBG releases more. SHBG gene variants shape your baseline level genetically. The Precision Peptide Genetic Test analyzes SHBG as part of Men’s Hormone insights across 14 pathways, 49 peptides, and 150+ genetic insights.
Why One-Size-Fits-All Peptide Protocols Fail
Peptide protocols fail many people not because the science is wrong, but because they're built for population averages. FTO, FOXO3, ACTN3, SHBG, and COMT variants mean weight management, longevity, muscle, and hormone biology works differently in everyone. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights to reveal exactly where your biology diverges.
The 49 Peptides Analyzed by the Precision Peptide Genetic Test
The Precision Peptide Genetic Test analyzes your genetic response to the pathways targeted by 49 unique compounds across five protocol families — GLP-1, growth hormone, androgens, estrogens, and vascular modulators. This post breaks down how each protocol family maps to genetic pathways, what the 49-peptide panel covers, and what your results reveal.
Genetics as a Guide, Not a Guarantee: What DNA Can and Cannot Tell You
Genetic testing reveals tendencies, not outcomes — a FOXO3 variant doesn't predict lifespan, a slow-COMT variant doesn't diagnose any condition, an ACTN3 XX genotype doesn't cap muscle growth. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights. Understanding what DNA can and cannot tell you is the difference between informed and overconfident.
Test Before You Invest: Genetic Testing Before Peptide Protocols
Before committing to a peptide protocol, genetic testing reveals how your body will actually respond across GLP-1 signaling, growth hormone axis, estrogen clearance, and sexual response pathways. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights. Test first. Invest second. That sequence is the entire premise of precision peptide decisions.
The Precision Health Stack: Genetics, Blood, Supplements, Protocols
The precision health stack is a 4-layer system: genetic testing as the foundation, blood work for state data, supplements and lifestyle for baseline support, and protocols as the intervention layer. The Precision Peptide Genetic Test anchors the stack — analyzing 14 pathways, 49 peptides, and 150+ genetic insights that shape how every layer above performs.

















